bpc 157 human clinical evidence BPC-157 and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded The Real BPC-157 Story: 544
Description
26 out of 63 (41%) patients had skin and mucosal changes

CB4211 is an analog, not native MOTS-c

The NIH Office of Dietary Supplements has established no Tolerable Upper Intake Level (UL), meaning these high label doses do not pose the safety risks their large numbers might suggest

this situation is known as a blown vein or "tissuing"

The Motherlode: 100+ Women Who Made Hip-Hop

Any treatment is provided only after evaluation by a licensed medical provider